Adjuvant Radiation Therapy for Ductal Carcinoma In Situ of the Breast: A Clinician’s Dilemma Chirag ShahFrank Vicini ASO Perspectives 06 June 2023 Pages: 6281 - 6283
Quality of ChatGPT Responses to Questions Related to Pancreatic Cancer and its Surgical Care Zorays MoazzamJordan CloydTimothy M. Pawlik ASO Research Letter 22 June 2023 Pages: 6284 - 6286
Creation and Implementation of a Monthly International Tumor Board: Experience of the Transatlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG) Jason K. SicklickCarol J. SwallowAlessandro Gronchi ASO Research Letter 24 July 2023 Pages: 6287 - 6289
Staging of the Axilla After Neoadjuvant Chemotherapy: Which Technique is Better? The Endless Debate Giacomo MontagnaMahmoud B. El-Tamer Breast Oncology 02 July 2023 Pages: 6290 - 6292
The Era of Flat Closure Mastectomy (Is Still Here). Are You Ready? Jennifer L. Baker Breast Oncology 16 August 2023 Pages: 6293 - 6295
Phyllodes Tumors of the Breast: Addressing the Gaps in Consensus Recommendations for Clinical Management Anna D. LouieLaura H. Rosenberger Breast Oncology 14 August 2023 Pages: 6296 - 6298
Validation of the Absent-Cell Theory for Staging Mucinous Appendiceal Cancer Frederick L. Greene Peritoneal Surface Malignancy 15 July 2023 Pages: 6299 - 6300
Perioperative Systemic Chemotherapy in Patients with Malignant Peritoneal Mesothelioma Undergoing Cytoreduction and HIPEC: Don’t Put the Cart Before the Horse H. Richard Alexander Peritoneal Surface Malignancy 26 June 2023 Pages: 6301 - 6303
Neoadjuvant Chemotherapy for Intrahepatic Cholangiocarcinoma: A Potential Paradigm Shift in Treatment Sequencing Aslam EjazTimothy M. Pawlik Hepatobiliary Tumors 26 July 2023 Pages: 6304 - 6305
Editorial Comment on: The Impact of Programmed Death-Ligand 1 Expression on Mismatch Repair Deficiency and Epstein–Barr Virus Status on Survival Outcomes in Patients with Stage II/III Gastric Cancer After Surgery Takehiko Yokobori Gastrointestinal Oncology 14 June 2023 Pages: 6306 - 6307
Peritoneal Cell-Free DNA: A Novel Biomarker for Recurrence in Pancreatic Cancer Angela SickelsTejeshwar JainVikas Dudeja Pancreatic Tumors 23 July 2023 Pages: 6308 - 6310
Commentary: Validation of Sublobar Resection for Middle Third Tumors: Advanced Imaging Technology Affords Patients a Viable Alternative to Lobectomy Eric A. LisznyaiAndrew M. Popoff Thoracic Oncology 22 July 2023 Pages: 6311 - 6312
Surgical Management of Incidentally Detected Pleural Disease in Lung Cancer Patients: A Complex Decision Sukumar KalvapudiSai Yendamuri Thoracic Oncology 07 July 2023 Pages: 6313 - 6314
Difficulty of Video-Assisted Thoracoscopic Surgery Segmentectomy: Proposal for a New Classification System—All “Segmentectomies” Are Not Created Equal Scott J. Swanson Thoracic Oncology 15 July 2023 Pages: 6315 - 6315
Editorial: Different Methods of Minimally Invasive Esophagojejunostomy After Total Gastrectomy for Gastric Cancer: Outcomes from Two Experienced Centers Benjamin R. VeenstraMatthew E. DixonSam G. Pappas Thoracic Oncology 12 August 2023 Pages: 6316 - 6317
Great Debates in Surgical Oncology: An Annals of Surgical Oncology Series Mitchell C. PosnerKelly M. McMasters Global Health Services Research 18 July 2023 Pages: 6318 - 6318
Great Debate: Limb Infusion for Melanoma: A Thing of the Past? Kristen E. RhodinDouglas S. TylerGeorgia M. Beasley Melanoma 17 July 2023 Pages: 6319 - 6324
Top Melanoma Articles from 2021 to Inform Your Cancer Practice Jeffrey E. Gershenwald Melanoma 26 July 2023 Pages: 6325 - 6331
The Association Between Pregnancy Timing and Cumulative Exposure on Survival in Melanoma Sarah B. BateniRinku SutradharNicole J. Look Hong Melanoma 29 June 2023 Pages: 6332 - 6338
ASO Visual Abstract: The Association Between Pregnancy Timing and Cumulative Exposure on Survival in Melanoma Sarah B. BateniRinku SutradharNicole J. Look Hong ASO Visual Abstract 05 August 2023 Pages: 6339 - 6339
Timing of Adjuvant Immunotherapy in Stage III Melanoma, Does it Matter? Kristen E. RhodinSin-Ho JungGeorgia M. Beasley Melanoma 22 July 2023 Pages: 6340 - 6352
ASO Author Reflections: It’s About Time? Kristen E. RhodinGeorgia M. Beasley ASO Author Reflections 23 July 2023 Pages: 6353 - 6354
ASO Visual Abstract: Timing of Adjuvant Immunotherapy in Stage III Melanoma, Does It Matter? Kristen E. RhodinSin-Ho JungGeorgia M. Beasley ASO Visual Abstract 14 August 2023 Pages: 6355 - 6356
RE: A Clinical Decision Tool to Calculate Pretest Probability of Sentinel Lymph Node Metastasis in Primary Cutaneous Melanoma Peter A. PrietoMatthew S. GoldbergBrian Martin Melanoma Open access 03 July 2023 Pages: 6357 - 6358
The Role of Clinicopathologic Nomograms for Melanoma in the Era of Gene Expression Profiling Raghav TripathiKaren LarsonWesley Y. Yu Melanoma 27 June 2023 Pages: 6359 - 6360
Comparing Methods for Targeted Axillary Dissection in Breast Cancer Patients: A Nationwide, Retrospective Study Frederikke MunckPernille JepsenTove H. F. Tvedskov Breast Oncology Open access 03 July 2023 Pages: 6361 - 6369
ASO Author Reflections: Comparison of Two-Step Methods for Targeted Axillary Dissection in Denmark Frederikke MunckNiels KromanTove Tvedskov ASO Author Reflections 23 June 2023 Pages: 6370 - 6371
ASO Visual Abstract: Comparing Methods for Targeted Axillary Dissection in Breast Cancer Patients: A Nationwide, Retrospective Study Frederikke MunckPernille JepsenTove H. F. Tvedskov ASO Visual Abstract 19 July 2023 Pages: 6372 - 6373
National Trends in “Going Flat” After Mastectomy Morgan K. JohnsonChandler S. CortinaAmanda L. Kong Breast Oncology 17 July 2023 Pages: 6374 - 6382
ASO Author Reflections: The Potential Impact of the “Going Flat” Movement on National Rates of Post-Mastectomy Breast Reconstruction Morgan K. JohnsonChandler S. CortinaAmanda L. Kong ASO Author Reflections 13 July 2023 Pages: 6383 - 6384
ASO Visual Abstract: National Trends in “Going Flat” After Mastectomy Morgan K. JohnsonChandler S. CortinaAmanda L. Kong ASO Visual Abstract 19 July 2023 Pages: 6385 - 6385
Phyllodes Tumors of the Breast: Canadian National Consensus Document Using Modified Delphi Methodology Jessica BogachApishanthi SriskandarajahCanadian Phyllodes Tumor Consensus Panel Breast Oncology 09 August 2023 Pages: 6386 - 6397
ASO Author Reflections: Development of Canadian National Consensus Statements on Phyllodes Tumors of the Breast Jessica BogachApishanthi SriskandarajahNicole Look Hong ASO Author Reflections 15 July 2023 Pages: 6398 - 6399
ASO Visual Abstract: Phyllodes Tumors of the Breast: Canadian National Consensus Document Using Modified Delphi Methodology Jessica BogachApishanthi Sriskandarajahthe Canadian Phyllodes Tumor Consensus Panel ASO Visual Abstract 09 August 2023 Pages: 6400 - 6400
Changes in Surgical Management of the Axilla Over 11 Years – Report on More Than 1500 Breast Cancer Patients Treated with Neoadjuvant Chemotherapy on the Prospective I-SPY2 Trial Judy C. BougheyHongmei YuRita A. Mukhtar Breast Oncology 28 June 2023 Pages: 6401 - 6410
ASO Visual Abstract: Changes in Surgical Management of the Axilla Over 11 Years—Report on Over 1500 Breast Cancer Patients Treated with Neoadjuvant Chemotherapy on the Prospective I-SPY2 Trial Judy C. BougheyHongmei YuRita Mukhtar ASO Visual Abstract 03 August 2023 Pages: 6411 - 6412
Breast-Conserving Therapy is Associated with Improved Survival Without an Increased Risk of Locoregional Recurrence Compared with Mastectomy in Both Clinically Node-Positive and Node-Negative Breast Cancer Patients Elizaveta VasilyevaJeremy HammElaine McKevitt Breast Oncology 26 June 2023 Pages: 6413 - 6424
ASO Visual Abstract: Breast-Conserving Therapy is Associated with Improved Survival without an Increased Risk of Locoregional Recurrence Compared to Mastectomy in Both Clinically Node Positive and Node Negative Breast Cancer Patients Elizaveta VasilyevaJeremy HammElaine McKevitt ASO Visual Abstract 30 July 2023 Pages: 6425 - 6426
Landmark Series: The Cancer Genome Atlas and the Study of Breast Cancer Disparities Josh A. JohnsonBrandon J. MooreLisa A. Newman Breast Oncology 16 August 2023 Pages: 6427 - 6440
Neoadjuvant Immunotherapy in Early, Triple-Negative Breast Cancers: Catching Up with the Rest Leah KimMagdalena ComanTristen S. Park Breast Oncology 22 June 2023 Pages: 6441 - 6449
ASO Author Reflections: Immunotherapy and Breast Cancer—Spotlight on Early Stage TNBC Tristen S. ParkLajos Pusztai ASO Author Reflections 20 July 2023 Pages: 6450 - 6451
ASO Visual Abstract: Neoadjuvant Immunotherapy in Early Triple-Negative Breast Cancers—Catching up with the Rest Leah KimMagdalena ComanTristen S. Park ASO Visual Abstract 03 July 2023 Pages: 6452 - 6453
Germline Genetic Testing Among Women ≤ 45 Years of Age with Ductal Carcinoma In Situ Versus Invasive Breast Cancer in a Large Integrated Health Care System Diana S. HsuSheng-Fang JiangVeronica C. Shim Breast Oncology 29 June 2023 Pages: 6454 - 6461
Associations Between Hospital Volume and Overall Survival After Surgery in Older Patients with Breast Cancer Sam Z. ThaljiChandler S. CortinaAmanda L. Kong Breast Oncology 14 June 2023 Pages: 6462 - 6470
ASO Author Reflections: Extending Optimal Care for Breast Cancer to the Elderly Population Sam Z. ThaljiChandler S. CortinaAmanda L. Kong ASO Author Reflections 27 June 2023 Pages: 6471 - 6472
ASO Visual Abstract: Associations Between Hospital Volume on Overall Survival After Surgery in Older Patients with Breast Cancer Sam Z. ThaljiChandler S. CortinaAmanda L. Kong ASO Visual Abstract 17 July 2023 Pages: 6473 - 6474
Clinical Behavior, Management, and Treatment Response of Estrogen Receptor Low (1–10%) Breast Cancer Dan MoldoveanuTanya L. HoskinJudy C. Boughey Breast Oncology 17 July 2023 Pages: 6475 - 6483
ASO Author Reflections: Low Estrogen Receptor (ER) Expression Breast Cancer Behaves More like ER Negative Disease and Influences Management Dan MoldoveanuMatthew P. GoetzJudy C. Boughey ASO Author Reflections 24 July 2023 Pages: 6484 - 6485
ASO Visual Abstract: Clinical Behavior, Management, and Treatment Response of Estrogen Receptor-Low (1-10%) Breast Cancer Dan MoldoveanuTanya L. HoskinJudy C. Boughey ASO Visual Abstract 30 July 2023 Pages: 6486 - 6487
Intraoperative Examination of Retro-Areolar Margin is not Routinely Necessary During Nipple-Sparing Mastectomy for Cancer Francesca SerioElena MannaLucio Fortunato Breast Oncology 30 June 2023 Pages: 6488 - 6496